metformin tirzepatide Outperforms in T2D Treatment | Donald E. Casey, Jr., MD, MPH, MBA, MACP, FAHA, DFAAPL posted on the topic Metformin + Tirzepatide for Weight

It is important to distinguish between a direct pharmacologic effect of the medication and indirect consequences of the physiologic changes these drugs produce

The primary measure for long-term blood sugar is HbA1c, and studies show Tirzepatide can lower these levels by 1.24% to 2.58%

Imaging data from 50 patients with DSA-confirmed solitary MDVO who received endovascular treatment and 50 patients without stroke, confirmed by follow-up MRI, was included

The primary differences are delivery method and price, not the medication itself

Disclaimer: The information in this blog post about post-acute sequelae of SARS-CoV-2 is provided for general informational purposes only and may not reflect current medical thinking or practices

These drugs, originally approved for type 2 diabetes, lower A1c, slow digestion to increase satiety, increase fat utilization, and have led to dramatic weight loss results of around 12%17% of body weight after 48 weeks of use